In the webinar “Pharmaceutical Deal Outlook: U.S. and European Perspectives,” Frank Aquila, Matt Hurd, Carsten Berrar, Olivier de Vilmorin and Jeremy Kutner discuss the outlook for M&A deals in the sector. The group of partners, who came together from S&C’s New York, Frankfurt, Paris and London offices, focus in particular on outlining how patent law impacts the tenor of mergers and acquisitions, how the regulatory landscape in both the United States and Europe is affecting dealmaking, and the different considerations for acquirers as opposed to sellers.
An Update on the FTC’s Non-Compete Rule
A Discussion of Non-Compete Agreements and Their Enforceability
Major Developments in National Security Enforcement, Part Three
Major Developments in National Security Enforcement, Part Two
Enforcement Actions Related to Alleged Impairment of Whistleblower Activity and New Whistleblower Programs
Major Developments in National Security Enforcement
ESG Considerations for Financial Institutions in 2024
2023 Headwinds in M&A and Outlook for 2024
Corporate Governance: What to Expect in 2024
Employment and Contracting Litigation After the Supreme Court’s Affirmative Action Decision
The Australian-American Partnership to Address Climate Change
How the DOJ’s and FTC’s Draft Merger Guidelines May Affect M&A
Supreme Court’s Recent Polansky Decision on the False Claims Act
Recent Developments with SEC’s Whistleblowing Program
Carve-Out Transactions in Europe: Key Considerations and Recent Experiences
Supreme Court’s Recent Slack Technologies Decision
U.S. Clean Energy Tax Credits: Where We Are and Where We Are Going
Implications of EU Court of Justice Judgment in the Fiat Case for Future State Aid Investigations
The Impact of COVID-19 on Consumer and Retail M&A
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Aligned Money Show
Gorse Culture PODcast : The H.R. Detective Agency!
HCI Leadership Revolution
The Ramsey Show
Planet Money